BIOMAT Database Logo BIOMAT Database Logo

Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis. 1999

C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Department of Medicine, Policlinic, Philipps-University, Marburg, Germany. baerwald@mailer.uni-marburg.de

Catecholamines modulate lymphocyte function via stimulation of beta2-adrenergic receptors (beta2R). Previous investigations revealed a decreased density of beta2R on peripheral blood mononuclear cells (PBMC) in patients with chronic rheumatic diseases. Aim of the present study was to determine the impact of this decrease on catecholamine response of PBMC from patients with rheumatoid arthritis (RA) in vitro. PBMC from 17 patients with RA and 12 healthy blood donors (HD) were investigated. Beta2R were determined by a radioligand binding assay. The effects of epinephrine (E) and norepinephrine (NE) on PBMC proliferation were studied using cells activated with pokeweed mitogen (PWM) and monoclonal anti-CD3-antibodies (OKT3), respectively. In parallel, alpha1- or beta-receptor antagonist were added to the culture to determine the specificity of the catecholaminergic effects. The results showed that depending on the stimulus and the catecholamine concentration employed E and NE exert inhibitory (OKT3) or stimulatory signals (PWM) on lymphocyte proliferation. Inhibitory effects could be abolished by adding beta-antagonist, while stimulatory signals were diminished after addition of alpha1- of beta-antagonist. Patients with RA showed a significantly reduced density of beta2R compared to HD paralleled by a significantly reduced influence of catecholamines on lymphocyte function. The study demonstrates the intricate relationship between PBMC reactivity and catecholamine effects that are mediated via alpha1- and beta-adrenergic receptors. In this respect the reduced catecholamine response of PBMC from RA patients may contribute to the pathogenic process of RA.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011043 Pokeweed Mitogens Proteins isolated from the roots of the pokeweed, Phytolacca americana, that agglutinate some erythrocytes, stimulate mitosis and antibody synthesis in lymphocytes, and induce activation of plasma cells. Lectins, Pokeweed,Pokeweed Lectin,Pokeweed Lectins,Pokeweed Mitogen,Pokeweed Mitogen Isolectin,Isolectin, Pokeweed Mitogen,Lectin, Pokeweed,Mitogen Isolectin, Pokeweed,Mitogen, Pokeweed,Mitogens, Pokeweed
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic

Related Publications

C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
CATECHOLAMINE EXCRETION IN PATIENTS WITH RHEUMATOID ARTHRITIS.
December 1964, Arthritis and rheumatism,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
In vitro response of peripheral blood lymphocytes from patients with rheumatoid arthritis to lipopolysaccharides.
March 1980, The Journal of laboratory and clinical medicine,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Catecholamine metabolism in the patients with rheumatoid arthritis.
May 1977, The Tohoku journal of experimental medicine,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
In vitro stimulation of lymphocytes from patients with rheumatoid arthritis.
November 1985, Clinical immunology and immunopathology,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
The redox state in lymphocytes from patients with rheumatoid arthritis.
October 1986, The Journal of rheumatology,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
January 1982, Journal of immunology (Baltimore, Md. : 1950),
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Impaired blastogenic response of lymphocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
June 1976, The Journal of rheumatology,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
The purine nucleotide content of lymphocytes from patients with rheumatoid arthritis.
January 1994, International journal of clinical pharmacology research,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Lymphocytes from patients with rheumatoid arthritis produce agalactosylated IgG in vitro.
June 1992, Clinical and experimental immunology,
C G Baerwald, and M Wahle, and T Ulrichs, and D Jonas, and A von Bierbrauer, and P von Wichert, and G R Burmester, and A Krause
Increased EA-rosette formation by lymphocytes from patients with rheumatoid arthritis.
August 1977, Clinical and experimental immunology,
Copied contents to your clipboard!